Looking technically very strong.Looking technically very strong. Should it go beyond 12.30 zone then it will enter in 15 zone.
Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
−0.1757EUR
−22.28 MEUR
3.15 MEUR
129.58 M
About ONCOPEPTIDES AB
Sector
CEO
Sofia Heigis
Headquarters
Stockholm
Website
Employees (FY)
57
Founded
2000
FIGI
BBG00G2HF249
Oncopeptides AB is a pharmaceutical company, which is involved in the development of targeted therapies for hematological diseases. The firm focuses on its product candidate melflufen, a peptide conjugated alkylator, belonging to a new class of drugs called peptidase enhanced cytotoxics, which targets aminopeptidases and rapidly releases alkylating agents into tumor cells. The company was founded by Rolf Larsson, Rolf Lewensohn, Joachim Gullbo, Kristina Luthman, Hans Ehrsson, and Peter Nygren on September 5, 2000 and is headquartered in Stockholm, Sweden.
ONCO looking to break out soon.So I while back we looked at ONCO breaking up from a large descending triangle and we found a good entry.
Now a possible new entry point will present itself.
Breaking up from the previous triangle we've now completed an impulse with correction pattern, finding support on the 0.5 fib (red circles).
ONCO starting to look bullish.ONCO has huge FA bullish potential and now also starting to look bullish from a TA point of view.
What should we do?
GREEN scenario: Wait for the retest of the smaller blue trendline and potentially buy there to get a lower price but with less bullish confirmation. Or wait for the larger trendline
ONCO keeping an eye on breakout.ONCO has been consolidating for quite a while. The reason I'm looking at it now is because it has just found support on the daily cloud (not on the chart displayed) and just arrived at the bottom of the weekly cloud. So now let's see if it will enter the weekly cloud.
Once it does, I see a bullish s
What's ONCO's story at the moment?'When in doubt, zoom out'. As ONCO is confusing me somewhat with mixed signals, I decided to take a look at the weekly chart only for now.
So we are inside a descending triangle. Which got broken to the downside during the 'covid crash', but the price recovered nicely back into it.
Long story short,
Close eye on ONCOONCO is approaching an potential area of support on the daily cloud and long term horizontal area of support/resistance.
So I'm keeping an close eye on its reaction there.
If it can hold AND break the downward (blue) trendline, then that represents a good entry point.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ONCOPEPTIDES AB O.N. stocks are traded under the ticker OND.
ONCOPEPTIDES AB O.N. is going to release the next earnings report on May 3, 2024. Keep track of upcoming events with our Earnings Calendar.
OND earnings for the last quarter are −0.04 EUR per share, whereas the estimation was −0.06 EUR resulting in a 34.74% surprise. The estimated earnings for the next quarter are −0.06 EUR per share. See more details about ONCOPEPTIDES AB O.N. earnings.
ONCOPEPTIDES AB O.N. revenue for the last quarter amounts to 2.20 M EUR despite the estimated figure of 2.14 M EUR. In the next quarter revenue is expected to reach 2.36 M EUR.
Yes, you can track ONCOPEPTIDES AB O.N. financials in yearly and quarterly reports right on TradingView.
OND net income for the last quarter is −7.26 M EUR, while the quarter before that showed −3.50 M EUR of net income which accounts for −107.62% change. Track more ONCOPEPTIDES AB O.N. financial stats to get the full picture.
No, OND doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, OND shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ONCOPEPTIDES AB O.N. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 57.00 employees. See our rating of the largest employees — is ONCOPEPTIDES AB O.N. on this list?
We've gathered analysts' opinions on ONCOPEPTIDES AB O.N. future price: according to them, OND price has a max estimate of 0.86 EUR and a min estimate of 0.34 EUR. Read a more detailed ONCOPEPTIDES AB O.N. forecast: see what analysts think of ONCOPEPTIDES AB O.N. and suggest that you do with its stocks.